HIF-1 alpha inhibitors (NCI)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHIF-1 alpha inhibitors (NCI)
Drug Alias Namehypoxia inducible factor 1 alpha inhibitors (NCI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor 1 alpha inhibitors
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A